A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of multi-dose regimens of IPI-145 on lung
function in mild asthmatic subjects following allergen challenge.